| COMPOSITION: | Each film coated tablet in tablet contains Enteric coated Rabeprazole 20 mg embedded in Ondansetron Hydrochloride eq. to Ondansetron 4 mg. |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Renvorab-ON tablets contain Rabeprazole an acid inhibitor and Ondansetron an anti-emetic that stops vomiting. It is indicated in the treatment of hyperacidity and food pipe ulcers associated with various medical, surgical and diagnostic conditions, GERD and to prevent nausea and vomiting due to hyperacidity, indigestion and surgery. |
| SIDE EFFECTS: | Common side effects are headache, constipation, weakness, drowsiness, headache, nausea, vomiting, gas, joint pain, diarrhea and dizziness. |
| DOSAGE/DIRECTIONS FOR USE: | AS PRESCRIBED BY PHYSICIAN |
